Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > new offer?

<< Previous

Bullboard Posts

Next >>

Post by annegelon Dec 22, 2017 6:49pm

177 Views

Post# 27219934

new offer?

Looks like the market believes there won't be a higher bid...

I found this article dating MAY 31, 2013 : https://uk.reuters.com/article/us-cvtech-takeover/canadas-cvtech-says-it-rejected-takeover-bids-in-january-march-idUKBRE94U1A920130531

I don't know who the bidder was at the time but they were willing to pay $1.95 four years ago. The article says : "CVTech Group Inc CVT.TO, which provides services to electric utilities, said it had received and rejected multiple takeover offers from a New York Stock Exchange-listed electrical contractor".

Maybe one of these? https://seekingalpha.com/article/1060761-5-stocks-to-watch-in-power-grid-construction

$1.95 is pretty cheap when you compare to what some company was willing to pay 4 or 5 years ago.

Any toughts?

annegel

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China